Home > Clinical Trials
Check All Search

Saved trials

Active, not recruiting
NCT03734029
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
557 Enrollment(s)
208 Study location(s)
Interventional (Phase III)
Breast Cancer
Not yet recruiting
NCT05900206
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
370 Enrollment(s)
7 Study location(s)
Interventional (Phase II)
Breast Cancer
Not yet recruiting
NCT05869591
DOAC in Patients With Child B Liver Cirrhosis
32 Enrollment(s)
0 Study location(s)
Interventional (Phase II)
Liver Cirrhosis
Active, not recruiting
NCT03505710
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer
181 Enrollment(s)
21 Study location(s)
Interventional (Phase II)
Non-Small Cell Lung Cancer
Completed
NCT04752059
Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases
15 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Breast Cancer Stage IV
Recruiting
NCT05732506
Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria
456 Enrollment(s)
35 Study location(s)
Observational
Auricular Fibrillation
Recruiting
NCT05458401
EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan
200 Enrollment(s)
21 Study location(s)
Observational
HER2-positive Breast Cancer
Not yet recruiting
NCT05852769
A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants
18 Enrollment(s)
0 Study location(s)
Interventional (Phase I)
Healthy Volunteers